P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 498, doi. 10.1038/cgt.2008.100
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 6
Results: 7
1
2
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 489, doi. 10.1038/cgt.2008.98
- By:
- Publication type:
- Article
3
Multitarget therapy of malignant cancers by the head-to-tail tandem array multiple shRNAs expression system.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 516, doi. 10.1038/cgt.2008.102
- By:
- Publication type:
- Article
4
Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 508, doi. 10.1038/cgt.2008.103
- By:
- Publication type:
- Article
5
Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 532, doi. 10.1038/cgt.2008.104
- By:
- Publication type:
- Article
6
Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
7
Armed replicating adenoviruses for cancer virotherapy.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 6, p. 473, doi. 10.1038/cgt.2009.3
- By:
- Publication type:
- Article